Identifying factors associated with depression among men living with HIV/AIDS and undergoing antiretroviral therapy: a cross-sectional study in Heilongjiang, China

• Published in: Health and quality of life outcomes 2018-09, Vol.16 (1), p.190-190, Article 190
• Main Authors: Liu, Huan, Zhao, Miaomiao, Ren, Jiaojiao, Qi, Xinye, Sun, Hong, Qu, Lemeng, Yan, Cunling, Zheng, Tong, Wu, Qunhong, Cui, Yu
• Format: Article
• Language: English
• Subjects: Acquired immune deficiency syndrome; Adult; AIDS; Anti-Retroviral Agents - therapeutic use; Antiretroviral agents; Antiretroviral drugs; Antiretroviral therapy; Anxiety; Care and treatment; CD4 antigen; China - epidemiology; Cross-Sectional Studies; Demographic variables; Demographics; Demography; Depression; Depressive Disorder - epidemiology; Female; Highly active antiretroviral therapy; HIV; HIV infections; HIV Infections - drug therapy; HIV Infections - ethnology; HIV Infections - psychology; HIV patients; HIV/AIDS; Human immunodeficiency virus; Humans; Influencing factors; Male; Men; Mental depression; Middle Aged; Prevalence; Regression models; Self Concept; Side effects; Sleep; Social Stigma; Social support; Surveys and Questionnaires; Therapy; Young Adult
• ISSN: 1477-7525; 1477-7525
• DOI: 10.1186/s12955-018-1020-x

Depression is common among people living with HIV/AIDS; however, studies focusing on the depression of men living with HIV/AIDS are limited. Therefore, we examined the prevalence of depression and its associated factors among men living with HIV/AIDS in China. A cross-sectional questionnaire survey was conducted in Harbin, China between March and August in 2013. Two-hundred twenty participants completed the Burns Depression Checklist, the Berger HIV Stigma, and the SPIEGEL questionnaire. We also investigated demographics, family support, hostility, and the antiretroviral therapy side effects of men living with HIV/AIDS. More than 40% of respondents had depressive symptoms and worry about the health was the major symptom of depression (40.9%). The logistic regression model indicated that bad sleep quality (OR = 3.452), hostility (OR = 1.120), perceived discrimination (OR = 1.110), and antiretroviral therapy side effects (OR = 1.083) were positively associated with depression. Family support (OR = 0.860) was negatively associated with depression for men living with HIV/AIDS. Demographic variables, HIV infection route, disease duration, and CD4+ cell count had no significant associations with depression. Although China's work of national HIV prevention and treatment has made much progress during the past several years, the prevalence of depression among men living with patients with HIV/AIDS is still prominent. The strongest factor associated with depression among men living with HIV/AIDS was sleep quality. Future studies should explore the effects of interventions for depression among PLWHA.